| 1 |
Khan Z, Abourehab MAS, Parveen N, Kohli K, Kesharwani P. Recent advances in microbeads-based drug delivery system for achieving controlled drug release. J Biomater Sci Polym Ed 2023;34:541-64. [PMID: 36168111 DOI: 10.1080/09205063.2022.2127237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Parveen N, Sheikh A, Abourehab MA, Karwasra R, Singh S, Kesharwani P. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023. [DOI: 10.1016/j.eurpolymj.2023.111993] [Reference Citation Analysis]
|
| 3 |
Dongsar TT, Dongsar TS, Gupta N, Almalki WH, Sahebkar A, Kesharwani P. Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104371] [Reference Citation Analysis]
|
| 4 |
Parveen N, Abourehab MAS, Thanikachalam PV, Khar RK, Kesharwani P. Nanocrystals as an emerging nanocarrier for the management of dermatological diseases. Colloids Surf B Biointerfaces 2023;225:113231. [PMID: 36907135 DOI: 10.1016/j.colsurfb.2023.113231] [Reference Citation Analysis]
|
| 5 |
Parveen N, Abourehab MA, Shukla R, Thanikachalam PV, Jain GK, Kesharwani P. Immunoliposomes as an emerging nanocarrier for breast cancer therapy. European Polymer Journal 2023;184:111781. [DOI: 10.1016/j.eurpolymj.2022.111781] [Reference Citation Analysis]
|
| 6 |
Rehman U, Abourehab MA, Alexander A, Kesharwani P. Polymeric micelles assisted combinatorial therapy: Is it new hope for pancreatic cancer? European Polymer Journal 2023;184:111784. [DOI: 10.1016/j.eurpolymj.2022.111784] [Reference Citation Analysis]
|
| 7 |
Tsering Dongsar T, Sonam Dongsar T, Abourehab MA, Gupta N, Kesharwani P. Emerging application of magnetic nanoparticles for breast cancer therapy. European Polymer Journal 2023. [DOI: 10.1016/j.eurpolymj.2023.111898] [Reference Citation Analysis]
|
| 8 |
Alzahrani N, Al Jurdi A, Riella LV. Immune checkpoint inhibitors in kidney transplantation. Curr Opin Organ Transplant 2023;28:46-54. [PMID: 36579684 DOI: 10.1097/MOT.0000000000001036] [Reference Citation Analysis]
|
| 9 |
Aziz A, Rehman U, Sheikh A, Abourehab MAS, Kesharwani P. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy. J Biomater Sci Polym Ed 2023;34:398-418. [PMID: 36083788 DOI: 10.1080/09205063.2022.2121592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Fu X, Rehman U, Wei L, Chen ZS, Abourehab MAS, Kesharwani P, Cheng ZH. Silver-dendrimer nanocomposite as emerging therapeutics in anti-bacteria and beyond. Drug Resist Updat 2023;68:100935. [PMID: 36774747 DOI: 10.1016/j.drup.2023.100935] [Reference Citation Analysis]
|
| 11 |
Zeng L, Gowda BHJ, Ahmed MG, Abourehab MAS, Chen ZS, Zhang C, Li J, Kesharwani P. Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer 2023;22:10. [PMID: 36635761 DOI: 10.1186/s12943-022-01708-4] [Reference Citation Analysis]
|
| 12 |
Liu Z, Parveen N, Rehman U, Aziz A, Sheikh A, Abourehab MAS, Guo W, Huang J, Wang Z, Kesharwani P. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Mol Cancer 2023;22:8. [PMID: 36635659 DOI: 10.1186/s12943-022-01696-5] [Reference Citation Analysis]
|
| 13 |
Alisha H. Mujawar, Sachin S. Navale, Nilofer S. Sayyad, Shrutika R. Kadam, Rushikesh M. Sankpal, Punam D. Mali. Dostarlimab : A Step Against Cancer. IJARSCT 2022. [DOI: 10.48175/ijarsct-7658] [Reference Citation Analysis]
|
| 14 |
Fatima M, Karwasra R, Almalki WH, Sahebkar A, Kesharwani P. Galactose engineered nanocarriers: Hopes and hypes in cancer therapy. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111759] [Reference Citation Analysis]
|
| 15 |
Musyuni P, Bai J, Sheikh A, Vasanthan KS, Jain GK, Abourehab MA, Lather V, Aggarwal G, Kesharwani P, Pandita D. Precision Medicine: Ray of Hope in Overcoming Cancer Multidrug Resistance. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100889] [Reference Citation Analysis]
|
| 16 |
Alkholifi FK, Alsaffar RM. Dostarlimab an Inhibitor of PD-1/PD-L1: A New Paradigm for the Treatment of Cancer. Medicina 2022;58:1572. [DOI: 10.3390/medicina58111572] [Reference Citation Analysis]
|
| 17 |
Kousar K, Ahmad T, Naseer F, Kakar S, Anjum S. Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma. Cancers 2022;14:4458. [DOI: 10.3390/cancers14184458] [Reference Citation Analysis]
|
